Tag Archives: Irving-based Biote wants to bring hormone replacement therapy into the ‘mainstream’

Irving-based hormone replacement therapy provider Biote goes public via a blank check company Friday, hoping a cash injection will be a springboard for accelerated growth as it aims for $166 million in revenue this year. “Dallas was a great place to grow up from,” said Biote CEO Terry Weber, who moved to North Texas from Orange County, Calif., in 2018 …

Read More »